Hepatitis: Screening and Testing Methods

The development of serological tests for the identification of a counteracting agent to this newly discovered illness has been spurred by the disclosure of hepatitis infection (HV). Intravenous drug users, hemodialysis patients, hemophiliacs, and blood transfusion recipients are among the groups most seriously at risk of becoming infected with HV. The prevalence of post-transfusion hepatitis has significantly decreased because of screening blood donors for HV antagonists. One of the main problems with HV illness is the progression of chronic hepatitis, which can lead to cirrhosis and hepatocellular cancer in 50–60% of cases

 

    Related Conference of Hepatitis: Screening and Testing Methods

    November 14-15, 2022

    13th International Conference on Liver Diseases & Hepatology

    Amsterdam, Netherlands
    November 28-29, 2022

    World Conference on Digestive and metabolic diseases

    Kyoto, Japan
    December 07-08, 2022

    45th World Strock Summit

    Prague, Czech Republic
    December 19-20, 2022

    2nd World Conference on Gastroenterology and Digestive Diseases

    Amsterdam, Netherlands
    January 30-31, 2023

    18th Euro-Global Gastroenterology Conference

    Barcelona, Spain
    July 18-19, 2023

    2nd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    August 23-24, 2023

    29th World Conference on Gastroenterology & Hepatology

    Toronto, Canada
    August 30-31, 2023

    22st World Congress on Gastrointestinal Cancer

    Dublin, Ireland

    Hepatitis: Screening and Testing Methods Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in